Epidermal Growth Factor Receptor (EGFR) Pathway Biomarkers in the Randomized Phase III Trial of Erlotinib Versus Observation in Ovarian Cancer Patients with No Evidence of Disease Progression after First-Line Platinum-Based Chemotherapy
Titel:
Epidermal Growth Factor Receptor (EGFR) Pathway Biomarkers in the Randomized Phase III Trial of Erlotinib Versus Observation in Ovarian Cancer Patients with No Evidence of Disease Progression after First-Line Platinum-Based Chemotherapy
Auteur:
Despierre, Evelyn Vergote, Ignace Anderson, Ryan Coens, Corneel Katsaros, Dionyssios Hirsch, Fred R. Boeckx, Bram Varella-Garcia, Marileila Ferrero, Annamaria Ray-Coquard, Isabelle Berns, Els M. J. J. Casado, Antonio Lambrechts, Diether Jimeno, Antonio